Compare PGIM India Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
-
5.0
Min SIP Amount
₹1000
₹100
Expense Ratio
2.37
1.86
NAV
₹9.94
₹37.79
Fund Started
19 Nov 2024
25 Jun 2018
Fund Size
₹88.38 Cr
₹6658.41 Cr
Exit Load
Exit load of 0.50%, if redeemed within 90 days.
Exit load of 1% if redeemed within 15 days.
1 Year
11.49%
7.38%
3 Year
-
27.18%
5 Year
-
16.78%
Equity
97.80%
97.60%
Cash
0.02%
2.37%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 11.31% |
Divi's Laboratories Ltd. | 10.32% |
Dr. Reddy's Laboratories Ltd. | 6.36% |
Aster DM Healthcare Ltd. | 6.24% |
JB Chemicals & Pharmaceuticals Ltd. | 6.09% |
Max Healthcare Institute Ltd. | 5.33% |
Rubicon Research Ltd. | 5.00% |
Mankind Pharma Ltd. | 4.95% |
Ajanta Pharma Ltd. | 4.80% |
Abbott India Ltd. | 3.74% |
Sun Pharmaceutical Industries Ltd. | 11.20% |
Cipla Ltd. | 9.43% |
Dr. Reddy's Laboratories Ltd. | 7.27% |
Mankind Pharma Ltd. | 6.34% |
Divi's Laboratories Ltd. | 6.22% |
Biocon Ltd. | 5.85% |
Lupin Ltd. | 4.80% |
Aurobindo Pharma Ltd. | 3.91% |
Syngene International Ltd. | 2.99% |
Alkem Laboratories Ltd. | 2.90% |
Name
-
-
Start Date
-
-
Description
The scheme seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
19 Nov 2024
25 Jun 2018
